Physician

Urology

Dr. Marc C. Gittelman, MD

Dr. Marc C. Gittelman works in the field of Urology. He went to Icahn School of Medicine at Mount Sinai. Icahn School of Medicine at Mount Sinai is ranked 20 in research and 62 in primary care medicine He has 1 awards "Fellow (FACS)". Marc Gittelman is a published doctor. He published 32 publications, including: 'Diagnosis of acute testicular torsion using radionuclide scanning.' He is registered with Medicare and accepts Medicare payments.

Publications

A Phase 2, Randomized, Double-Blind, Efficacy and Safety Study of Oxybutynin Vaginal Ring for Alleviation of Overactive Bladder Symptoms in Women.
PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study.
Rapid efficacy of the highly selective ?(1A)-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phas...
Long-term efficacy and tolerability of once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate cancer.
Silodosin in the treatment of the signs and symptoms of benign prostatic hyperplasia: a 9-month, open-label extension study.
Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 ph...
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer.
Topical alprostadil (PGE1) for the treatment of female sexual arousal disorder: in-clinic evaluation of safety and efficacy.
Solifenacin treatment in men with overactive bladder: effects on symptoms and patient-reported outcomes.
Efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction in elderly men and those with underlying conditions: an integ...
Reductions in overactive bladder-related incontinence from pooled analysis of phase III trials evaluating treatment with solifenacin.
Vardenafil improves patient satisfaction with erection hardness, orgasmic function, and overall sexual experience, while improving quality of life in men with erectile...
Diagnosis of acute testicular torsion using radionuclide scanning.
Extended duration of efficacy of vardenafil when taken 8 hours before intercourse: a randomized, double-blind, placebo-controlled study.
An evaluation of semen characteristics in men 45 years of age or older after daily dosing with tadalafil 20mg: results of a multicenter, randomized, double-blind, plac...
Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial.
The POTENT II randomised trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction.
Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia.
Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomi...
A 1-year, open label, randomized phase II dose finding study of degarelix for the treatment of prostate cancer in North America.
Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial.
The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrin...
Dutasteride improves objective and subjective disease measures in men with benign prostatic hyperplasia and modest or severe prostate enlargement.
Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia: therapeutic options for the man at risk.
Efficacy, tolerability and safety of darifenacin, an M(3) selective receptor antagonist: an investigation of warning time in patients with OAB.
A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis.
First dose efficacy of alfuzosin once daily in men with symptomatic benign prostatic hyperplasia.
Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride...
Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence.
Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence.
Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia.

Schools

Mount Sinai School Of Medicine Of New York University
Mount Sinai School of Medicine
Tufts University

Procedures Preformed

Bioidentical Hormone Replacement Therapy
Cystometry
Cystoscopy
Cystourethroscopy and Transurethral Resection of Bladder Neck
View All

Doctors Specialties

Age Management Medicine
Integrative Medicine
Male Adult Urology
Urology

Accepted Insurances

Awards

Fellow (FACS)

Education

Mount Sinai School of Medicine
Icahn School of Medicine at Mount Sinai

Hospital

Memorial Hospital of Tampa

Drug Facts

NPI NUMBER		1174587604
NPPES Provider LastName		GITTELMAN
NPPES Provider FirstName		MARC
NPPES Provider ZIPCode		331801226
NPPES Provider State		FL
Specialty Description		Urology
Total Claim Count		1819.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1174587604
Last Name Of The Provider	GITTELMAN
First Name Of The Provider	MARC
View All

Similar Doctors

	Dr. Akshay Bhandari, MD This Doctor is OpenDoctor Recommended.
	Dr. George E. Munoz, MD This Doctor is OpenDoctor Recommended.
	Dr. Arnon Krongrad, MD This Doctor is OpenDoctor Recommended.
	Dr. Harvey R. Samowitz, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark H. Christ, MD This Doctor is OpenDoctor Recommended.
	Dr. Stephen Tannenbaum, MD This Doctor is OpenDoctor Recommended.
	Dr. Lawrence Winton, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark B. Weitzenfeld, MD This Doctor is OpenDoctor Recommended.
	Dr. Norman Bloom, MD This Doctor is OpenDoctor Recommended.
	Dr. Jay H. Kim, MD